Bill
Biosimilar Red Tape Elimination Act This bill deems all biosimilars licensed by the Food and Drug Administration (FDA) interchangeable with their reference products. A biosimilar is a biological product (e.g., a drug or vaccine) that is…
Overview and Timeline are the same for every version. Text and Votes below change with the version you select.
Introduced in Senate — Jun 4, 2025
congress.gov did not return a machine-readable document, but the official printed PDF is available.